EBS 4.83 (-6.58%)
US29089Q1058Drug ManufacturersDrug Manufacturers - Specialty & Generic

Emergent BioSolutions (EBS) Competitor Comparison

We are evaluating the key criteria listed to compare Emergent BioSolutions (EBS) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Earnings per Share - EBS ranking 50 / 54

These are the competitors of Emergent BioSolutions in the industry Drug Manufacturers - Specialty & Generic ranked by earnings per share
1. Linc LNC
18.02
2. Zoetis ZTS
5.47
3. Amphastar Pharmaceuticals AMPH
3.06
4. Collegium Pharmaceutical COLL
1.86
5. Taro Pharmaceutical Industries TARO
1.43
6. Supernus Pharmaceuticals SUPN
1.31
7. Alimera Sciences ALIM
1.05
8. Embecta EMBC
0.96
9. Eagle Pharmaceuticals EGRX
0.85
10. Elanco Animal Health ELAN
0.68
11. Phibro Animal Health PAHC
0.48
12. Procaps Group PROC
0.47
13. Vifor Pharma G2AB.F
0.46
14. PetIQ PETQ
0.37
15. Green Thumb Industries R9U2.F
0.28
16. Kamada KMDA
0.25
17. Kolinpharma KIP.MI
0.21
18. Cronos Group CRON
0.11
19. Ironwood Pharmaceuticals IRWD
0.01
20. Organogenesis Holdings ORGO
-0.01
21. Bausch Health Companies BHC
-0.13
22. Societal CDMO SCTL
-0.14
23. Theratechnologies THTX
-0.17
24. Ascend Wellness Holdings AAWH
-0.23
25. Tilray Brands TLRY
-0.28
26. OptiNose OPTN
-0.31
27. Curaleaf Holdings CURLF
-0.31
28. Amneal Pharmaceuticals AMRX
-0.38
29. Regencell Bioscience Holdings RGC
-0.42
30. Cumberland Pharmaceuticals CPIX
-0.46
31. Avadel Pharmaceuticals AVDL
-0.51
32. Jupiter Wellness JUPW
-0.59
33. Alpha Teknova TKNO
-0.59
34. SCYNEXIS SCYX
-0.75
35. ProPhase Labs PRPH
-0.81
36. Evolus EOLS
-0.81
37. Zynerba Pharmaceuticals ZYNE
-0.85
38. Journey Medical DERM
-0.92
39. Harrow Health HROW
-0.96
40. ANI Pharmaceuticals ANIP
-1.04
41. Perrigo PRGO
-1.15
42. Teva Pharmaceutical Industries TEVA
-1.45
43. Universe Pharmaceuticals UPC
-1.7
44. Ayr Wellness 3KJB.F
-1.81
45. Alvotech ALVO
-1.85
46. Pacira BioSciences PCRX
-2.18
47. Catalent CTLT
-2.28
48. Relmada Therapeutics RLMD
-2.87
49. Solid Biosciences SLDB
-3
50. Emergent BioSolutions EBS
-3.59
51. Flora Growth FLGC
-6.24
52. Biofrontera BFRI
-10.3
53. Neoleukin Therapeutics NLTX
-12.28
54. Clever Leaves Holdings CLVR
-12.63

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.